A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: DRUG: Filgrastim|DRUG: Pegfilgrastim
Sponsor: Ottawa Hospital Research Institute